PMH8 Projecting the Economic Outcomes of Switching Patients with Schizophrenia from Oral Atypical Antipsychotics to Once-Monthly Paliperidone Palmitate and Once-Every-Three-Months Paliperidone Palmitate.
Saved in:
| Title: | PMH8 Projecting the Economic Outcomes of Switching Patients with Schizophrenia from Oral Atypical Antipsychotics to Once-Monthly Paliperidone Palmitate and Once-Every-Three-Months Paliperidone Palmitate. |
|---|---|
| Authors: | Lin, D.1 (AUTHOR), Morrison, L.2 (AUTHOR), Pilon, D.3 (AUTHOR), Benson, C.4 (AUTHOR), Ghelerter, I.2 (AUTHOR), Vermette-Laforme, M.3 (AUTHOR), Lefebvre, P.3 (AUTHOR) |
| Source: | Value in Health. 2021 Supplement 1, Vol. 24, pS129-S129. 1p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
